Bronchiectasis pathophysiology

Bronchiectasis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Bronchiectasis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Bronchiectasis pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Bronchiectasis pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Bronchiectasis pathophysiology
CDC on Bronchiectasis pathophysiology
Bronchiectasis pathophysiology in the news
Blogs on Bronchiectasis pathophysiology
Directions to Hospitals Treating Bronchiectasis
Risk calculators and risk factors for Bronchiectasis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2], Saarah T. Alkhairy, M.D.

Overview

Bronchiectasis involves cycles of infections and inflammation that result in alveolar damage and inelastic dilated bronchi. Damage to the airway results in airflow obstruction and impaired clearance of secretions.

Pathophysiology

The following events summarize the pathophysiology of bronchiectasis:

• Dilation of the bronchial walls results in airflow obstruction and impaired clearance of secretions.
• The dilated areas interrupt normal air pressure of the bronchial tubes, causing sputum to pool inside the dilated areas instead of being pushed upward.
• The sputum contains elastase, interleukin-8, tumor necrosis factor alpha (TNF-a), and prostanoids.
• The pooled sputum provides an environment favorable to the growth of infectious pathogens.
• Recurrent infections are followed inflammation and infiltration of neutrophils, macrophages, and T-lymphocytes.
• The more infection that the lungs experience, leads to the sustained inflammation, consequently, damage to the alveoli in the lungs.
• With more injury to the lung tissue, the elasticity in the bronchial tubes is reduced and the tubes are dilated, which creates a perpetual destructive cycle

Cole's Cycle

The following events summarize Cole's cycle (Cole's "vicious cycle hypothesis"), which is the most widely known model of the development of bronchiectasis:

• Two factors are required for the development of bronchiectasis:
  • Persistent infection
  • Host defense derangement
• Impaired mucociliary clearance due to the genetic susceptibility may cause environmental insult.
• Insults result in persistence of microbes in the sinobronchial tree.
• The microbial infection can cause chronic inflammation, which may result in tissue damage and impaired mucociliary motility.
• Inflammation ensues more infection, which in turn ensues more inflammation.

Immune Response

• Bronchiectasis involves the activity of reactive oxygen species (ROS), elastases, and matrix metalloproteinases (MMPs):
  • Reactive oxygen species (ROS)
    • A by product for the metabolism of oxygen
    • Increased concentration may result in cell structure damage

• Elastase
  • Protease that catalyzes the breaks down of elastin.
  • Elastin plus collagen determine the mechanical properties of connective tissue.

• Matrix metalloproteinases (MMPs)
  • Responsible for the degradation of the majority of the extracellular proteins during normal tissue turn over.
  • Inflammation may result in epithelial injury and mucus secretion via increased concentrations of ROS, elastase ciliotoxin, and mucus secretogogues.
  • Epithelial injury and mucus hypersecretion lead to chronic bronchial infection, reduced mucociliary clearance, and plugging of the airway - which all eventually leads to airway damage and bronchiectasis.

The diagram below depicts the immune response for bronchiectasis:

• 

  Schematic representation of a vicious circle of events which occurs during chronic bronchial infection. IL: interleukin; TNF: tumour necrosis factor; LT: leukotriene; MMP: matrix metalloproteinase
  European Respiratory Journal

Gross Pathology

Bronchiectasis Source:Case courtesy of Dr Yale Rosen, Radiopaedia.org, rID: 9307

References

​​ ​ Template:WH Template:WS